Pipeline Report 2021: Promising drugs tick along across a range of conditions
COVID vaccines and therapeutics receive all the headlines — with good reason — but the pharma pipeline is bursting with A-grade candidates across a range of conditions.
Most recent articles by Surani Fernando
Biogen’s touted Alzheimer’s drug receives thumbs-down from FDA advisory panel
The agency will issue its final verdict on approval in March.
